The US Commercial organization, which is in the Global Hospital & Biosimilars organization, is comprised of over 200 products, spanning more than 10 therapeutic areas, with annual revenue of over $2.5B. The US Commercial Biosimilars Portfolio Lead has responsibility for managing the combined Inflammation & Immunology (I&I) and Oncology biosimilars (BSM) portfolios, with net revenue of ~$0.9B, within the US Commercial organization. This includes eight BSM assets - Abrilada, Inflectra, Nivestym, Nyvepria, Retacrit, Ruxience, Trazimera, Zirabev. The Biosimilars Portfolio Lead will be responsible for 1) driving BSM in-market strategy and performance, lifecycle dynamics, profitability, and go-to-market approaches, 2) unlocking new avenues for incremental profitable payer access in close partnership with USMA and the customer facing organization, and 3) providing direct leadership of the US Commercial BSM team. The leader reports directly to the US Commercial Lead and serves on the US Commercial Leadership Team.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Manager
Number of Employees
5,001-10,000 employees